Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 12/2011

01-12-2011 | Special Article

Recommendations and expert opinion on the treatment of locally advanced rectal cancer in Spain

Authors: Cristina Grávalos, Pilar García-Alfonso, Ruth Afonso, Virginia Arrazubi, Antoni Arrivi, Juan Carlos Cámara, Jaume Capdevila, Auxiliadora Gómez-España, Adelaida Lacasta, José Luis Manzano, Mercedes Salgado, Javier Sastre, Eduardo Díaz-Rubio

Published in: Clinical and Translational Oncology | Issue 12/2011

Login to get access
Metadata
Title
Recommendations and expert opinion on the treatment of locally advanced rectal cancer in Spain
Authors
Cristina Grávalos
Pilar García-Alfonso
Ruth Afonso
Virginia Arrazubi
Antoni Arrivi
Juan Carlos Cámara
Jaume Capdevila
Auxiliadora Gómez-España
Adelaida Lacasta
José Luis Manzano
Mercedes Salgado
Javier Sastre
Eduardo Díaz-Rubio
Publication date
01-12-2011
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 12/2011
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-011-0747-1

Other articles of this Issue 12/2011

Clinical and Translational Oncology 12/2011 Go to the issue

Research Articles

Trifunctional antibodies induce efficient antitumour activity with immune cells from head and neck squamous cell carcinoma patients after radio-chemotherapy treatment

Research Articles

FP3: a novel VEGF blocker with antiangiogenic effects in vitro and antitumour effects in vivo

Educational Series / Red Series

Real-time intravital imaging of cancer models

Editorial

Multidisciplinary approach to oesophageal cancer

Research Articles

Transthoracic oesophagectomy with lymphadenectomy in 100 oesophageal cancer patients. Multidisciplinary approach

Research Articles

Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits